CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Olanzapine

奥氮平 杂质对照品Olanzapine Impurities

EP50 个杂质条目50 impurity entries

本页汇总 奥氮平 的 50 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 50 impurity reference standards of Olanzapine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 奥氮平(Olanzapine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesSpectrophotometric determination of olanzapine, fluoxetine HCL and its impurity using univariate and chemometrics methods reinforced by latin hypercube sampling: Validation and eco-friendliness assessments
    BMC chemistry · 2024 · Ghanem HN et al.  ·  PMID 39420434  ·  DOI
  2. 杂质研究Impurity studiesDevelopment of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms
    Journal of pharmaceutical and biomedical analysis · 2011 · Krishnaiah Ch et al.  ·  PMID 21075576  ·  DOI
  3. 杂质研究Impurity studiesDevelopment of a simple and stability-indicating RP-HPLC method for determining olanzapine and related impurities generated in the preparative process
    The Analyst · 2011 · Cui D et al.  ·  PMID 21695344  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisHeating under high-frequency inductive conditions: application to the continuous synthesis of the neurolepticum olanzapine (Zyprexa)
    Angewandte Chemie (International ed. in English) · 2013 · Hartwig J et al.  ·  PMID 23893845  ·  DOI
  • 合成方法Synthesis[A synthesis of tritium-labeled olanzapine]
    Bioorganicheskaia khimiia · 2005 · Shevchenko VP et al.  ·  PMID 16119462  ·  DOI

奥氮平 —— 原料药与杂质对照品Olanzapine — drug substance & impurities

共 50 个条目(含原料药本体)50 items incl. the drug substance
Olanzapine Impurity 1(Olanzapine EP Impurity A) structure
EPA
奥氮平杂质1(奥氮平EP杂质A)Olanzapine Impurity 1(Olanzapine EP Impurity A)
Olanzapine Impurity 1(Olanzapine EP Impurity A)
CAS No.138564-59-7
Chemical FormulaC12H9N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 2 (Olanzapine EP Impurity B) structure
EPB
奥氮平杂质2 (奥氮平EP杂质B)Olanzapine Impurity 2 (Olanzapine EP Impurity B)
Olanzapine Impurity 2 (Olanzapine EP Impurity B)
CAS No.221176-49-4
Chemical FormulaC12H10N2OS
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 3 (Olanzapine EP Impurity C) structure
EPC
奥氮平杂质3 (奥氮平EP杂质C)Olanzapine Impurity 3 (Olanzapine EP Impurity C)
Olanzapine Impurity 3 (Olanzapine EP Impurity C)
CAS No.719300-59-1
Chemical FormulaC18H22Cl2N4S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 4 (Olanzapine EP Impurity D) structure
EPD
奥氮平杂质4 (奥氮平EP杂质D)Olanzapine Impurity 4 (Olanzapine EP Impurity D)
Olanzapine Impurity 4 (Olanzapine EP Impurity D)
CAS No.174794-02-6
Chemical FormulaC17H20N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 5(Olanzapine EP Impurity E) structure
EPE
奥氮平杂质5(奥氮平EP杂质E)Olanzapine Impurity 5(Olanzapine EP Impurity E)
Olanzapine Impurity 5(Olanzapine EP Impurity E)
CAS No.1017241-36-9
Chemical FormulaC17H20N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 7(Olanzapine EP Impurity G) structure
EPG
奥氮平杂质7(奥氮平EP杂质G)Olanzapine Impurity 7(Olanzapine EP Impurity G)
Olanzapine Impurity 7(Olanzapine EP Impurity G)
CAS No.161696-76-0
Chemical FormulaC16H18N4S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 9(Olanzapine EP Impurity I) structure
EPI
奥氮平杂质9(奥氮平EP杂质I)Olanzapine Impurity 9(Olanzapine EP Impurity I)
Olanzapine Impurity 9(Olanzapine EP Impurity I)
CAS No.1070876-09-3
Chemical FormulaC28H26N6S2
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 10(Olanzapine EP Impurity J) structure
EPJ
奥氮平杂质10(奥氮平EP杂质J)Olanzapine Impurity 10(Olanzapine EP Impurity J)
Olanzapine Impurity 10(Olanzapine EP Impurity J)
CAS No.2749356-65-6
Chemical FormulaC24H19N5S2
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Pamoate Hydrate structure
—
奥氮平 双羟萘酸盐 水合物Olanzapine Pamoate Hydrate
Olanzapine Pamoate Hydrate
CAS No.221373-18-8
Chemical FormulaC17H20N4S·C23H16O6·H2O
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 6 structure
6
奥氮平杂质6Olanzapine Impurity 6
Olanzapine Impurity 6
CAS No.1017241-34-7
Chemical FormulaC17H20N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 11 structure
11
奥氮平杂质11Olanzapine Impurity 11
Olanzapine Impurity 11
CAS No.174756-45-7
Chemical FormulaC17H20N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 12 structure
12
奥氮平杂质12Olanzapine Impurity 12
Olanzapine Impurity 12
CAS No.138564-61-1
Chemical FormulaC17H22N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 13 structure
13
奥氮平杂质13Olanzapine Impurity 13
Olanzapine Impurity 13
CAS No.138564-58-6
Chemical FormulaC6H6N2S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 14 structure
14
奥氮平杂质14Olanzapine Impurity 14
Olanzapine Impurity 14
CAS No.1493-27-2
Chemical FormulaC6H4FNO2
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 15 structure
15
奥氮平杂质15Olanzapine Impurity 15
Olanzapine Impurity 15
CAS No.2554975-45-8
Chemical FormulaC17H14N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 16 structure
16
奥氮平杂质16Olanzapine Impurity 16
Olanzapine Impurity 16
CAS No.138564-60-0
Chemical FormulaC12H11N3S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 16 Monomer structure
16
奥氮平杂质16 单体Olanzapine Impurity 16 Monomer
Olanzapine Impurity 16 Monomer
CAS No.612503-08-9
Chemical FormulaC12H11N3S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 17 structure
17
奥氮平杂质17Olanzapine Impurity 17
Olanzapine Impurity 17
CAS No.1320360-87-9
Chemical FormulaC17H20N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 18 structure
18
奥氮平杂质18Olanzapine Impurity 18
Olanzapine Impurity 18
CAS No.1320360-86-8
Chemical FormulaC15H18N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 19 structure
19
奥氮平杂质19Olanzapine Impurity 19
Olanzapine Impurity 19
CAS No.873895-41-1
Chemical FormulaC12H11N3S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 20 structure
20
奥氮平杂质20Olanzapine Impurity 20
Olanzapine Impurity 20
CAS No.935272-10-9
Chemical FormulaC18H20N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 25 structure
25
奥氮平杂质25Olanzapine Impurity 25
Olanzapine Impurity 25
CAS No.52833-34-8
Chemical FormulaC6H6N2
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 26 structure
26
奥氮平杂质26Olanzapine Impurity 26
Olanzapine Impurity 26
CAS No.1083078-77-6
Chemical FormulaC34H38N8S2
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 27 structure
27
奥氮平杂质27Olanzapine Impurity 27
Olanzapine Impurity 27
CAS No.2586222-74-2
Chemical FormulaC12H10N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 28 structure
28
奥氮平杂质28Olanzapine Impurity 28
Olanzapine Impurity 28
CAS No.1313411-74-3
Chemical FormulaC24H18N4O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 29 structure
29
奥氮平杂质29Olanzapine Impurity 29
Olanzapine Impurity 29
CAS No.639460-79-0
Chemical FormulaC17H18N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 30 structure
30
奥氮平杂质30Olanzapine Impurity 30
Olanzapine Impurity 30
CAS No.1797009-17-6
Chemical FormulaC18H22N4S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 33 structure
33
奥氮平杂质33Olanzapine Impurity 33
Olanzapine Impurity 33
CAS No.24878-25-9
Chemical FormulaC12H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 34 structure
34
奥氮平杂质34Olanzapine Impurity 34
Olanzapine Impurity 34
CAS No.2217-65-4
Chemical FormulaC12H8N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 36 structure
36
奥氮平杂质36Olanzapine Impurity 36
Olanzapine Impurity 36
CAS No.1902955-67-2
Chemical FormulaC17H20N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 41 structure
41
奥氮平杂质41Olanzapine Impurity 41
Olanzapine Impurity 41
CAS No.2585173-71-1
Chemical FormulaC29H28N6S2
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 4-d3 structure
4-D3
奥氮平杂质4-d3Olanzapine Impurity 4-d3
Olanzapine Impurity 4-d3
CAS No.1189732-75-9
Chemical FormulaC17H17D3N4OS
Purity>95%询价On request
Olanzapine Impurity 43 structure
43
奥氮平杂质43Olanzapine Impurity 43
Olanzapine Impurity 43
CAS No.41940-47-0
Chemical FormulaC6H7NO2S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 44 structure
44
奥氮平杂质44Olanzapine Impurity 44
Olanzapine Impurity 44
CAS No.1231161-31-1
Chemical FormulaC12H10N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 45 structure
45
奥氮平杂质45Olanzapine Impurity 45
Olanzapine Impurity 45
CAS No.1807606-58-1
Chemical FormulaC12H12N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 47 structure
47
奥氮平杂质47Olanzapine Impurity 47
Olanzapine Impurity 47
CAS No.612507-13-8
Chemical FormulaC12H10N2S2
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 48 structure
48
奥氮平杂质48Olanzapine Impurity 48
Olanzapine Impurity 48
CAS No.1330277-34-3
Chemical FormulaC17H18N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 49 structure
49
奥氮平杂质49Olanzapine Impurity 49
Olanzapine Impurity 49
CAS No.2518067-58-6
Chemical FormulaC17H20N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 50 structure
50
奥氮平杂质50Olanzapine Impurity 50
Olanzapine Impurity 50
CAS No.1319722-10-5
Chemical FormulaC12H10N2OS
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 52 structure
52
奥氮平杂质52Olanzapine Impurity 52
Olanzapine Impurity 52
CAS No.101-80-4
Chemical FormulaC12H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 55 structure
55
奥氮平杂质55Olanzapine Impurity 55
Olanzapine Impurity 55
CAS No.52063-45-3
Chemical FormulaC9H10N2S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 61 (Mixture of E/Z-isomers) structure
61
奥氮平杂质61 (混合E/Z构型)Olanzapine Impurity 61 (Mixture of E/Z-isomers)
Olanzapine Impurity 61 (Mixture of E/Z-isomers)
CAS No.2485860-97-5
Chemical FormulaC17H20N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 62 structure
62
奥氮平杂质62Olanzapine Impurity 62
Olanzapine Impurity 62
CAS No.1355034-54-6
Chemical FormulaC18H22N4S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 63 structure
63
奥氮平杂质63Olanzapine Impurity 63
Olanzapine Impurity 63
CAS No.87895-89-4
Chemical FormulaC13H13NO2S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 64 structure
64
奥氮平杂质64Olanzapine Impurity 64
Olanzapine Impurity 64
CAS No.393802-93-2
Chemical FormulaC16H17NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 65 structure
65
奥氮平杂质65Olanzapine Impurity 65
Olanzapine Impurity 65
CAS No.78267-24-0
Chemical FormulaC14H12ClNO3S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 70 structure
70
奥氮平杂质70Olanzapine Impurity 70
Olanzapine Impurity 70
CAS No.948550-95-6
Chemical FormulaC13H14N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Olanzapine Impurity 7-d8 structure
7-D8
奥氮平杂质7-d8Olanzapine Impurity 7-d8
Olanzapine Impurity 7-d8
CAS No.786686-82-6
Chemical FormulaC16H10D8N4S
Purity>95%询价On request
Olanzapine Impurity 11-d3 structure
11-D3
奥氮平杂质11-d3Olanzapine Impurity 11-d3
Olanzapine Impurity 11-d3
CAS No.1190006-36-0
Chemical FormulaC17H17D3N4OS
Purity>95%询价On request
Olanzapine Impurity 48-d3 structure
48-D3
奥氮平杂质48-d3Olanzapine Impurity 48-d3
Olanzapine Impurity 48-d3
CAS No.1794756-31-2
Chemical FormulaC17H15D3N4OS
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

奥氮平 —— 研究文献与合成路线Olanzapine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 奥氮平 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Olanzapine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms
    Krishnaiah Ch, Vishnu Murthy M, Kumar R, et al. · Journal of pharmaceutical and biomedical analysis · 2011 · 被引 13cited 13
  2. Development of a simple and stability-indicating RP-HPLC method for determining olanzapine and related impurities generated in the preparative process
    Cui D, Li Y, Lian M, et al. · The Analyst · 2011 · 被引 11cited 11
  3. Identification of oxidative degradation impurities of olanzapine drug substance as well as drug product
    Rao PS, Ray UK, Hiriyanna SG, et al. · Journal of pharmaceutical and biomedical analysis · 2011 · 被引 9cited 9
  4. Spectrophotometric determination of olanzapine, fluoxetine HCL and its impurity using univariate and chemometrics methods reinforced by latin hypercube sampling: Validation and eco-friendliness assessments
    Ghanem HN, El-Zaher AA, Mahmoud ST, et al. · BMC chemistry · 2024 · 被引 2cited 2
  5. Isolation, identification, and synthesis of two oxidative degradation products of olanzapine (LY170053) in solid oral formulations
    Baertschi SW, Brunner H, Bunnell CA, et al. · Journal of pharmaceutical sciences · 2008 · 被引 15cited 15
  6. Isolation, identification and characterization of two novel process-related impurities in olanzapine
    Zhuang T, Zhang W, Cao L, et al. · Journal of pharmaceutical and biomedical analysis · 2018 · 被引 10cited 10

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE PURIFICATION OF OLANZAPINE
    MESAR TOMAZ, CASAR ZDENKO · 公开号 WO2011009831WO2011009831 · 2011
  2. IMPROVED PROCESSES FOR THE SYNTHESIS OF OLANZAPINE
    KOTHAKONDA KIRAN KUMAR, CHE DAQING, GUNTOORI BHASKAR REDDY · 公开号 EP2170902EP2170902 · 2010
  3. Improved processes for the synthesis of olanzapine
    GUNTOORI BHASKAR REDDY, CHE DAQING, KOTHAKONDA KIRAN KUMAR · 公开号 AU2008267704AU2008267704 · 2008
  4. Process for the purification of olanzapine
    — · 公开号 EP2292624EP2292624 · 2011
  5. PROCESS FOR THE PREPARATION OF OLANZAPINE
    KOVANYINE LAX Györgyi, NEMETH Gábor, KRASZNAI György, MESTERHAZY Norbert, et al. · 公开号 WO2007054750WO2007054750 · 2007

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

奥氮平 杂质谱研究要点Olanzapine — impurity profiling notes

下面这些是拿到 奥氮平 的 50 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 50 impurity entries for Olanzapine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances